Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia

Leukemia Research

Volumn 32, Issue 10, 2008, Pages 1637-1638

  Musto, Pellegrino ^a   Pietrantuono, Giuseppe ^a   Guariglia, Roberto ^a   Villani, Oreste ^a   Martorelli, Maria Carmen ^a   D'Auria, Fiorella ^a   Zonno, Antonia ^a   Lerose, Rosa ^a  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; DEXAMETHASONE; LENALIDOMIDE; MELPHALAN; PREDNISONE;

AGED; BLOOD TOXICITY; CASE REPORT; DISEASE COURSE; FOLLOW UP; HUMAN; LETTER; MALE; MENTAL DISEASE; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; PANCYTOPENIA; PERFORMANCE; PLASMA CELL; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; RELAPSE; REMISSION; SALVAGE THERAPY; SUBCUTANEOUS NODULE; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; HUMANS; IMMUNOLOGIC FACTORS; LEUKEMIA, PLASMA CELL; MALE; RECURRENCE; SALVAGE THERAPY; THALIDOMIDE;

EID: 44749092574     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.03.013     Document Type: Letter

References (8)

1. Hayman S.R., and Fonseca R. Plasma cell leukemia. Curr Treat Options Oncol 2 (2001) 205-216
2. Musto P., Rossini F., Gay F., et al. Efficacy and safety of bortezomib in patients with plasma cell leukemia. Cancer 109 (2007) 2285-2290
3. Saccaro S., Fonseca R., Veillon D.M., et al. Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature. Am J Hematol 78 (2005) 288-294
4. Johnston R.E., and Abdalla S.H. Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia. Leuk Lymphoma 43 (2002) 351-354
5. Petrucci M.T., Martini V., Levi A., et al. Thalidomide does not modify the prognosis of plasma cell leukemia patients: experience of a single center. Leuk Lymphoma 48 (2007) 180-182
6. Dimopoulos M., Spencer A., Attal M., et al. Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med 357 (2007) 2123-2132
7. Palumbo A., Falco P., Corradini P., et al. Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA-Italian Multiple Myeloma Network. J Clin Oncol 25 (2007) 4459-4465
8. Benson Jr. D.M., and Smith M.K. Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia. Leuk Lymphoma 48 (2007) 1423-1425